PT89730A - Processo para a preparacao de derivados de aminoacido inibidores da renina e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de aminoacido inibidores da renina e de composicoes farmaceuticas que os contem

Info

Publication number
PT89730A
PT89730A PT89730A PT8973089A PT89730A PT 89730 A PT89730 A PT 89730A PT 89730 A PT89730 A PT 89730A PT 8973089 A PT8973089 A PT 8973089A PT 89730 A PT89730 A PT 89730A
Authority
PT
Portugal
Prior art keywords
renin
contain
preparation
pharmaceutical compositions
aminoacid derivatives
Prior art date
Application number
PT89730A
Other languages
English (en)
Other versions
PT89730B (pt
Inventor
Dieter Ruppert
Bernward Scholkens
Rainer Henning
Hansjorg Urbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT89730A publication Critical patent/PT89730A/pt
Publication of PT89730B publication Critical patent/PT89730B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
PT89730A 1988-02-16 1989-02-16 Processo para a preparacao de derivados de aminoacido inibidores da renina e de composicoes farmaceuticas que os contem PT89730B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3804793A DE3804793A1 (de) 1988-02-16 1988-02-16 Renin-hemmende aminosaeurederivate

Publications (2)

Publication Number Publication Date
PT89730A true PT89730A (pt) 1989-10-04
PT89730B PT89730B (pt) 1994-03-31

Family

ID=6347510

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89730A PT89730B (pt) 1988-02-16 1989-02-16 Processo para a preparacao de derivados de aminoacido inibidores da renina e de composicoes farmaceuticas que os contem

Country Status (15)

Country Link
US (1) US5204357A (pt)
EP (1) EP0329013A3 (pt)
JP (1) JPH023665A (pt)
KR (1) KR890013053A (pt)
CN (1) CN1035286A (pt)
AU (1) AU626535B2 (pt)
DE (1) DE3804793A1 (pt)
DK (1) DK69389A (pt)
FI (1) FI890699L (pt)
HU (1) HU203226B (pt)
IL (1) IL89304A0 (pt)
NO (1) NO890635L (pt)
NZ (1) NZ227976A (pt)
PT (1) PT89730B (pt)
ZA (1) ZA891135B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3717631A1 (de) * 1987-05-26 1988-12-15 Merck Patent Gmbh Aminosaeurederivate
ATE135368T1 (de) * 1989-09-12 1996-03-15 Hoechst Ag Aminosäurederivate mit reninhemmenden eigenschaften, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
EP0432974A1 (en) * 1989-12-08 1991-06-19 Merck & Co. Inc. Cyclic renin inhibitors
US5330737A (en) * 1991-12-06 1994-07-19 Mallinckrodt Medical, Inc. Nitrogen-sulfur ligands as opiate receptor drug mimics
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US9604930B2 (en) 2012-12-21 2017-03-28 Epizyme, Inc. Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
US10118918B2 (en) 2012-12-21 2018-11-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9365555B2 (en) 2012-12-21 2016-06-14 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9908887B2 (en) 2012-12-21 2018-03-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
JP2016505002A (ja) 2012-12-21 2016-02-18 エピザイム,インコーポレイティド ジヒドロイソキノリンまたはテトラヒドロイソキノリンを含有するprmt5阻害剤およびその使用
AU2015301196A1 (en) 2014-08-04 2017-01-12 Epizyme, Inc. PRMT5 inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435329A (en) * 1981-10-16 1984-03-06 American Cyanamid Company Substituted N-(ω-aroylpropionyl) derivatives of α-amino acids and esters thereof
DE3467754D1 (de) * 1983-10-03 1988-01-07 Squibb & Sons Inc Enkephalinase inhibitors
EP0236734A3 (de) * 1986-02-07 1988-05-11 Ciba-Geigy Ag Durch schwefelhaltigen Gruppen substituierte 5-Amino-4-hydroxyvalerylderivate
DE3732971A1 (de) * 1987-09-30 1989-04-20 Hoechst Ag Renin-hemmende dipeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
NZ227976A (en) 1991-12-23
ZA891135B (en) 1989-10-25
DK69389D0 (da) 1989-02-15
HUT50789A (en) 1990-03-28
EP0329013A2 (de) 1989-08-23
PT89730B (pt) 1994-03-31
FI890699A7 (fi) 1989-08-17
IL89304A0 (en) 1989-09-10
EP0329013A3 (de) 1991-03-13
HU203226B (en) 1991-06-28
JPH023665A (ja) 1990-01-09
US5204357A (en) 1993-04-20
AU626535B2 (en) 1992-08-06
FI890699A0 (fi) 1989-02-14
NO890635L (no) 1989-08-17
DE3804793A1 (de) 1989-08-24
NO890635D0 (no) 1989-02-15
CN1035286A (zh) 1989-09-06
KR890013053A (ko) 1989-09-21
DK69389A (da) 1989-08-17
AU2997789A (en) 1989-08-17
FI890699L (fi) 1989-08-17

Similar Documents

Publication Publication Date Title
PT92699A (pt) Processo para a preparacao de novos derivados heterociclicos inibidores da enzima 5-lipoxigenase e de composicoes farmaceuticas que os contem
PT90836A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT88949A (pt) Processo para a preparacao de inibidores de renina e de composicoes farmaceuticas que os contem
PT90713A (pt) Processo para a preparacao de novos n-derivados da 1-desoxi-nojirimicique, inibidores da alfa-glucosidase, e de composicoes farmaceuticas que os contem
PT92484A (pt) Processo para a preparacao de imidazois inibidores da acil-coa; colesterol-acetiltransferase e de composicoes farmaceuticas que os contem
PT89485A (pt) Processo para a preparacao de derivados dide-hidro de vitamina d3 e de composicoes farmaceuticas que os contem
PT92497A (pt) Processo para a preparacao de derivados de ureia de dipeptideos inibidores de enzimas, e de composicoes farmaceuticas que os contem
PT80892B (pt) Processo para a preparacao de derivados da quoinona e de composicoes farmaceuticas que os contem
PT95448A (pt) Processo para a preparacao de derivados azotados inibidores de proteases retrovirais e de composicoes farmaceuticas que os contem
PT98529A (pt) Processo para a preparacao de derivados de acetamida e de composicoes farmaceuticas que os contem
PT84277B (pt) Processo para a preparacao de derivados de indolizina e de composicoes que os contem
PT89405B (pt) Processo para a preparacao de derivados de isoquinolina e de composicoes farmaceuticas que os contem
PT82985B (pt) Processo para a preparacao de derivados de distamicina e de composicoes farmaceuticas que os contem
PT81041B (pt) Processo para a preparacao de derivados de etilenodiamina-monoamida e de composicoes farmaceuticas que os contem
PT98365A (pt) Processo para a preparacao de novos derivados de oxalilo e de composicoes farmaceuticas que os contem
PT89486A (pt) Processo para a preparacao de derivados 16-de-hidro de vitamina d3 e de composicoes farmaceuticas que os contem
PT82307B (pt) Processo para a preparacao de derivados da 4'-demetil-4-epipodofilotoxina e de composicoes farmaceuticas que os contem
PT90017A (pt) Processo para a preparacao de derivados de arilpiperazinilalcoxi de imidas ciclicas e de uma composicao farmaceutica que os contem
PT78986A (pt) Processo para a preparacao de derivados basicos de cumarina e de composicoes farmaceuticas que os contem
PT88679A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT92391A (pt) Processo para a sintese de nitro-imidazois e de composicoes farmaceuticas que os contem
PT90864A (pt) Processo para a preparacao de derivados de cromano e de composicoes farmaceuticas que os contem
PT90721A (pt) Processo para a preparacao de compostos de imidazoquinoxalina e de composicoes farmaceuticas que os contem
PT91803A (pt) Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem
PT90904A (pt) Processo para a preparacao de derivados de 3-oxo-propanonitrilo triciclicos e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930924

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950331